glp-1 news today october 2025 Weight-Loss Drug Demonstration Begins July 2026 glp-1 obesity drug news today

Experts say patients may still have options, but availability and affordability could become more challenging.

To date, non-alcoholic fatty liver disease (NAFLD) is the most frequent liver disease, affecting up to 70% of patients with diabetes

If something unexpected happens while youre away from home, its easier than ever to get care.

Learn how this medical weight management option may work for you.

Results Evidence suggests that GLP-1RAs mitigate psoriasis severity through systemic effects, including weight loss and improved glycemic control, and local immunomodulation, such as the regulation of invariant natural killer T (iNKT) cells and AMPK activation in psoriatic plaques

WHAT IS DIARRHEA